IP Verse

Modulators Of Complement Function - EP3359561

The patent EP3359561 was granted to Benjamin on Dec 30, 2020. The application was originally filed on Dec 1, 2016 under application number EP16853191A. The patent is currently recorded with a legal status of "Revoked".

EP3359561

BENJAMIN
Application Number
EP16853191A
Filing Date
Dec 1, 2016
Status
Revoked
Feb 17, 2023
Grant Date
Dec 30, 2020
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

ALGEMEEN OCTROOI EN MERKENBUREAUSep 29, 2021ALGEMEEN OCTROOI EN MERKENBUREAUADMISSIBLE

Patent Citations (7) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
INTERNATIONAL-SEARCH-REPORTUS2010179092
INTERNATIONAL-SEARCH-REPORTUS6221657
INTERNATIONAL-SEARCH-REPORTUS6268485
INTERNATIONAL-SEARCH-REPORTWO2005107785
OPPOSITIONWO2005003159
SEARCHWO2005003159
SEARCHWO9607738

Non-Patent Literature (NPL) Citations (17) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
INTERNATIONAL-SEARCH-REPORT- GARCIA BRANDON L. et al., "«Molecular Basis for Complement Recognition and Inhibition Determined by Crystallographic Studies of the Staphylococcal Complement Inhibitor (SCIN) Bound to C3c and C3b»", J Mol Biol., (20100910), vol. 402, no. 1, pages 17 - 29, XP027244119 [Y] 8 * doi:10.1016/j.jmb.2010.07.029, p.1-17 *
INTERNATIONAL-SEARCH-REPORT- VERONESE FRANCE SCO M. et al., "«Peptide and protein PEGylation: a review of problems and solutions»", Biomaterials, (20010000), vol. 22, no. 5, pages 405 - 417, XP004227886 [Y] 8, 25
OPPOSITION- DR. HEW, "human c3/cvf hybrid proteins: tools for a structure-function study of complement component C3", PhD Thesis, (20100000), pages 1 - 169-
OPPOSITION- Hew, B.E et al, "Understanding the structural basis of convertase stability: Fine mapping of residues required for CVF-like activity in human C3/CVF hybrid proteins", MOLECULAR IMMUNOLOGY, PERGAMON, GB, GB, (20100801), vol. 47, no. 13, ISSN 0161-5890, page 2257, XP027120284-
OPPOSITION- Fritzinger, D.C et al, "Functional characterization of human C3/cobra venom factor hybrid proteins for therapeutic complement depletion", DEVELOPMENTAL AND COMPARATIVE IMMUNOLOGY., PERGAMON PRESS., US, US, (20090101), vol. 33, no. 1, doi:10.1016/j.dci.2008.07.006, ISSN 0145-305X, pages 105 - 116, XP025560240
OPPOSITION- Carl-Wilhelm Vogel, Paul W. Finnegan, David C. Fritzinger, "Humanized cobra venom factor: Structure, activity, and therapeutic efficacy in preclinical disease models", MOLECULAR IMMUNOLOGY, PERGAMON, GB, GB, (20141001), vol. 61, no. 2, doi:10.1016/j.molimm.2014.06.035, ISSN 0161-5890, pages 191 - 203, XP055423384
OPPOSITION- Carl-Wilhelm Vogel, David C. Fritzinger, "Cobra venom factor: Structure, function, and humanization for therapeutic complement depletion", Toxicon, Pergamon, (20101201), vol. 56, no. 7, doi:10.1016/j.toxicon.2010.04.007, ISSN 00410101, pages 1198 - 1222, XP055046258
OPPOSITION- Hew Brian E et al, "Identification of intermolecular bonds between human factor B and Cobra Venom Factor important for C3 convertase stability", TOXICON, ELMSFORD, NY, US, US, (20200608), vol. 184, doi:10.1016/j.toxicon.2020.05.025, ISSN 0041-0101, pages 68 - 77, XP086234035
OPPOSITION- VERONESE F M, "Peptide and protein PEGylation: A review of problems and solutions.", Biomaterials, Elsevier, AMSTERDAM, NL, AMSTERDAM, NL, (20010301), vol. 22, no. 5, doi:10.1016/S0142-9612(00)00193-9, ISSN 0142-9612, pages 405 - 417, XP002237938
OPPOSITION- BRUIJN DE M H L, FEY G H, "HUMAN COMPLEMENT COMPONENT C3: CDNA CODING SEQUENCE AND DERIVED PRIMARY STRUCTURE", Proceedings of the National Academy of Sciences, National Academy of Sciences, US, US, (19850201), vol. 82, no. 03, doi:10.1073/pnas.82.3.708, ISSN 0027-8424, pages 708 - 712, XP009018561
OPPOSITION- KOCK M A, ET AL, "STRUCTURE AND FUNCTION OF RECOMBINANT COBRA VENOM FACTOR", Journal of Biological Chemistry, American Society for Biochemistry and Molecular Biology, US, US, (20040716), vol. 279, no. 29, doi:10.1074/jbc.M403196200, ISSN 0021-9258, pages 30836 - 30843, XP008075873
SEARCH[ ] - "Human modified C3 (D752G, E753S, D754G).", Geneseq, (19960521), Database accession no. AAR94030, URL: EBI, XP002788891 [ ] * sequence . *-
SEARCH- MASTELLOS DIMITRIOS C ET AL, "From orphan drugs to adopted therapies: Advancing C3-targeted intervention to the clinical stage", IMMUNOBIOLOGY, URBAN UND FISCHER VERLAG, DE, (20160616), vol. 221, no. 10, doi:10.1016/J.IMBIO.2016.06.013, ISSN 0171-2985, pages 1046 - 1057, XP029684330 [A] 1,4-15 * the whole document *
SEARCH- CARL-WILHELM VOGEL ET AL, "Humanized cobra venom factor: Structure, activity, and therapeutic efficacy in preclinical disease models", MOLECULAR IMMUNOLOGY., GB, (20141001), vol. 61, no. 2, doi:10.1016/j.molimm.2014.06.035, ISSN 0161-5890, pages 191 - 203, XP055423384 [A] 1,4-15 * abstract *
SEARCH- CARL-WILHELM VOGEL ET AL, "Cobra venom factor: Structure, function, and humanization for therapeutic complement depletion", TOXICON, (20101201), vol. 56, no. 7, doi:10.1016/j.toxicon.2010.04.007, ISSN 0041-0101, pages 1198 - 1222, XP055046258 [A] 1,4-15 * the whole document *
SEARCH- CARL-WILHELM VOGEL ET AL, "Summary", THROMBOSIS AND HAEMOSTASIS, DE, (20150501), vol. 113, no. 03, doi:10.1160/TH14-04-0300, ISSN 0340-6245, pages 548 - 552, XP055556312 [A] 1,4-15 * abstract *
SEARCH- ENRIQUE L LARGHI ET AL, "Modulators of complement activation: a patent review (2008 - 2013)", EXPERT OPINION ON THERAPEUTIC PATENTS, (20140601), vol. 24, no. 6, doi:10.1517/13543776.2014.898063, ISSN 1354-3776, pages 665 - 686, XP055161526 [A] 1,4-15 * the whole document *

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents